Recent decades have witnessed a tremendous increase in the number of new diagnostic methods and the introduction of many emerging new biomarkers in clinical diagnostic laboratories. The utility of biomarkers as screening and diagnostic tools is limited by many factors, such as sensitivity, specificity and predictive values. Another critical factor, not always carefully considered, is the availability of appropriate reference intervals that allow appropriate interpretation of results from tested individuals. In order for reference intervals to be available, it requires access to human biological specimens from healthy individuals (with the associated uncertainties on the definition of health in that context). Ideally, reference intervals should be determined by sampling a healthy population that span the whole age range and include both genders. Furthermore, since many reference intervals are being defined as dependent on several anthropometric parameters, optimal reference intervals should be established based on gender, ethnicity, age when pre-assessment of results revealed inter-dependency. Access to healthy individuals represents one major challenge for hospital-based clinical laboratories, since the vast majority of samples are drawn from hospitalized or clinic patients that are likely to suffer from clinical or sub-clinical disease and not truly represent a normal population. This challenge is particularly apparent with dealing with specific populations such as pediatrics or geriatrics.
